What is RDNT's health score?

RadNet, Inc. (RDNT) has a TradeApes health score of 56 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is RDNT's estimated fair value?

Based on our 5-year discounted cash flow model, RadNet, Inc.'s estimated fair value is $35.21 per share, representing a -33.2% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is RDNT undervalued or overvalued?

Our model currently rates RDNT as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for RDNT... Refresh in a moment for the full analysis.

RadNet, Inc. (RDNT)

Healthcare Overvalued low mixed

$52.68

Updated: 2026-06-04

TradeApes Score

Financial Strength

40 Weak

Operating Trend

68 Healthy

Relative Value

55 Mixed

Capital Allocation

55 Mixed

Risk

70 Healthy

Est. Fair Value $35.21

DCF Upside -33.2%

Sector Rank #4138 of 6750

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.